News & Updates

Risk of death 54 percent lower with remdesivir added for hospitalized COVID-19 patients on O₂ support
Risk of death 54 percent lower with remdesivir added for hospitalized COVID-19 patients on O₂ support
01 Jul 2024
SABA may be overprescribed for asthma in SG
SABA may be overprescribed for asthma in SG
27 Jun 2024
Off-label targeted drugs improve survival in CTEPH
Off-label targeted drugs improve survival in CTEPH
26 Jun 2024

Off-label pulmonary arterial hypertension (PAH)-targeted drugs may increase long-term survival in patients with chronic thromboembolic pulmonary hypertension (CTEPH), as shown in a study.

Off-label targeted drugs improve survival in CTEPH
26 Jun 2024
Working out in the COVID aftermath: How intense can one go?
Working out in the COVID aftermath: How intense can one go?
26 Jun 2024 byAudrey Abella

Outpatients with post-COVID condition (PCC) generally tolerated exercise without significant worsening of symptoms or decline in aerobic performance after 48 hours. However, they had lower muscle strength and aerobic capacity than controls, and even showed signs of POTS* and myopathy in a randomized crossover trial.

Working out in the COVID aftermath: How intense can one go?
26 Jun 2024